Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.09 - $7.63 $2,163 - $183,440
-24,042 Reduced 6.6%
340,417 $33,000
Q3 2022

Nov 14, 2022

BUY
$0.14 - $7.5 $6,390 - $342,352
45,647 Added 14.32%
364,459 $47,000
Q2 2022

Aug 12, 2022

SELL
$0.21 - $0.39 $7,519 - $13,963
-35,805 Reduced 10.1%
318,812 $68,000
Q1 2022

May 13, 2022

SELL
$0.34 - $0.5 $35,904 - $52,800
-105,600 Reduced 22.95%
354,617 $138,000
Q4 2021

Feb 11, 2022

SELL
$0.41 - $0.68 $98,577 - $163,493
-240,432 Reduced 34.32%
460,217 $222,000
Q3 2021

Nov 12, 2021

BUY
$0.53 - $0.91 $112,980 - $193,984
213,170 Added 43.73%
700,649 $391,000
Q2 2021

Aug 13, 2021

SELL
$0.57 - $0.99 $11,285 - $19,602
-19,800 Reduced 3.9%
487,479 $353,000
Q1 2021

May 13, 2021

SELL
$0.49 - $1.28 $140,434 - $366,848
-286,600 Reduced 36.1%
507,279 $426,000
Q4 2020

Feb 10, 2021

BUY
$0.36 - $0.55 $23,507 - $35,914
65,299 Added 8.96%
793,879 $354,000
Q3 2020

Nov 13, 2020

SELL
$0.33 - $0.62 $36,135 - $67,890
-109,500 Reduced 13.07%
728,580 $266,000
Q2 2020

Aug 13, 2020

SELL
$0.39 - $0.71 $43,680 - $79,520
-112,000 Reduced 11.79%
838,080 $558,000
Q1 2020

May 14, 2020

BUY
$0.25 - $1.14 $14,154 - $64,543
56,617 Added 6.34%
950,080 $479,000
Q4 2019

Feb 13, 2020

BUY
$0.22 - $0.27 $35,641 - $43,741
162,006 Added 22.15%
893,463 $212,000
Q3 2019

Nov 13, 2019

SELL
$0.25 - $0.31 $7,330 - $9,089
-29,320 Reduced 3.85%
731,457 $179,000
Q2 2019

Aug 12, 2019

SELL
$0.24 - $0.51 $4,358 - $9,262
-18,161 Reduced 2.33%
760,777 $246,000
Q1 2019

May 14, 2019

BUY
$0.23 - $0.35 $64,055 - $97,475
278,500 Added 55.65%
778,938 $258,000
Q4 2018

Feb 13, 2019

BUY
$0.2 - $0.45 $100,087 - $225,197
500,438 New
500,438 $129,000

Others Institutions Holding CPHI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About CHINA PHARMA HOLDINGS, INC.


  • Ticker CPHI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 50,449,700
  • Market Cap $10.1M
  • Description
  • China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. It...
More about CPHI
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.